Novelion Therapeutics Inc

TSX:NVLN (Canada)  
(Delisted) C$ 13.30 (0%) Dec 18
At Loss
Market Cap:
C$ 247.12M ($ 181.75M)
Enterprise V:
C$ 247.12M ($ 181.75M)
Volume:
-
Avg Vol (2M):
-
Market Cap C$ M 247.12
Enterprise Value C$ M 247.12
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book --
Price/Sales --
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) C$ M 179.00
EPS (TTM) C$ -3.91
Beneish M-Score 0
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % --
y-y EBITDA Growth Rate % --
EV-to-EBIT --
EV-to-EBITDA --
PEG --
Shares Outstanding M 18.93
Net Margin (%) --
Operating Margin % --
Pre-tax Margin (%) --
Quick Ratio --
Current Ratio --
ROA % (ttm) --
ROE % (ttm) --
ROIC % (ttm) --
Dividend Yield % --
Altman Z-Score --
Piotroski F-Score --
Positive ROA N
Positive CFROA N
Higher ROA y-y N
Cash flow > Earnings N
Lower Leverage y-y N
Higher Current Ratio y-y N
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

TSX:NVLN Number of Guru Trades

To

TSX:NVLN Volume of Guru Trades

To

Gurus Latest Trades with TSX:NVLN

No Available Data

TSX:NVLN is held by these investors

No Available Data

Novelion Therapeutics Inc Insider Transactions

No Available Data